Understanding FIP and a new drug showing promise against it

04/1/2013 | PetMD.com

A new drug may improve or prolong life for some cats with the deadly feline infectious peritonitis virus, according to information presented at a meeting of the American Animal Hospital Association, veterinarian Lorie Huston writes. Veterinarians Niels Pedersen and Alfred Legendre said FIP results from a mutation in a common virus combined with an impaired immune response in some cats. While there is no cure, Dr. Legendre observed that the drug polyprenyl immunostimulant helped some cats do better and may also improve longevity.

View Full Article in:

PetMD.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD